Women's Health

PHI researchers have a track record of leading and promoting research into female reproductive health. They are working to improve treatments for infertility and pregnancy related disorders.

1 in 12 women will be diagnosed with breast cancer before they are 75 years old. PHI researchers are developing new targeted approaches to breast cancer treatment.

The application of new protein based technologies is providing insights into female reproductive health conditions such as endometriosis and Polycystic Ovary Syndrome. These conditions, affecting about one in ten women, have a significant impact on the lives of many women and can also impact female fertility.

Clinical Studies in Women's Health

 

PHI Laboratories  with a focus on Women's Health:

  • Cancer Drug Discovery is finding new approaches to treating breast cancer.

  • Ovarian Cancer Biomarkers is leading novel approaches to detecting ovarian cancer.

  • Reproductive Hormones is mapping the changes in hormones that occur during menopause and exploring tests which could be used to improve the success rates for fertility treatments.

  • Ovarian Biology is expanding our understanding of the healthy ovary and what can happen when there are female fertility issues.

  • Implantation & Placental Development is studying the changes in a women’s womb essential to ensure a healthy start to life and developing new methods of female contraception.

  • Endometrial Remodelling is exploring how molecular insights seen in women with infertility, endometriosis and uterine bleeding disorders can be used to develop better treatments. 

  • Embryo Implantation is identifying and testing new compounds to protect against infection with sexually transmitted diseases.

  • Reproductive Development & Cancer is  determining the mechanisms that control the spread of ovarian cancer.

 

Other PHI Laboratories with an interest in the Women's Health theme include: